Edmonton, Canada

Beatrice Leveugle




Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2005-2009

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Beatrice Leveugle: Innovator in Immunotherapy

Introduction

Beatrice Leveugle is a prominent inventor based in Edmonton, Canada. She has made significant contributions to the field of immunotherapy, particularly in the treatment of prostate cancer. With a total of 3 patents to her name, her work has the potential to impact many lives.

Latest Patents

One of her latest patents is titled "Reagents and methods for inducing an immune response to prostate specific antigen." This invention involves an apparatus and method for treating prostate cancer by administering an antibody that specifically binds with prostate antigen. Another notable patent is "Therapeutic compositions that produce an immune response." This invention provides a method for stimulating the production of antibodies to a cryptic epitope on a soluble antigen. It involves administering a binding agent that forms a complex with the soluble antigen, thereby exposing the cryptic epitope and enabling the patient to generate antibodies that bind to it.

Career Highlights

Throughout her career, Beatrice has worked with various companies, including Altarex Medical Corp. and Altarex Corporation. Her innovative approaches have garnered attention in the medical community, particularly in the realm of cancer treatment.

Collaborations

Beatrice has collaborated with notable individuals in her field, including Ragupathy Madiyalakan and Antoine A Noujaim. These partnerships have furthered her research and development efforts.

Conclusion

Beatrice Leveugle's contributions to immunotherapy and her innovative patents highlight her role as a leading inventor in the medical field. Her work continues to pave the way for advancements in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…